120 related articles for article (PubMed ID: 2340771)
1. Intracellular pH, esterase activity, and DNA measurements of human lung carcinomas by flow cytometry.
Liewald F; Demmel N; Wirsching R; Kahle H; Valet G
Cytometry; 1990; 11(3):341-8. PubMed ID: 2340771
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of flow cytometrically determined DNA-ploidy, intracellular pH and esterase activity of non-small cell lung carcinomas.
Liewald F; Sunder-Plassmann L; Dienemann H; Kahle H; Wulf G; Valet G
Anal Cell Pathol; 1992 Mar; 4(2):103-14. PubMed ID: 1312857
[TBL] [Abstract][Full Text] [Related]
3. DNA distribution in non-small-cell lung carcinomas and its relationship to clinical behavior.
Volm M; Mattern J; Sonka J; Vogt-Schaden M; Wayss K
Cytometry; 1985 Jul; 6(4):348-56. PubMed ID: 2990835
[TBL] [Abstract][Full Text] [Related]
4. p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study.
Goukon Y; Sasano H; Nishihira T; Nagura H; Mori S
Anticancer Res; 1994; 14(3B):1305-12. PubMed ID: 7915093
[TBL] [Abstract][Full Text] [Related]
5. [Flow cytometric analysis of DNA content in lung cancer].
Liu GX
Zhonghua Jie He He Hu Xi Za Zhi; 1992 Oct; 15(5):290-2, 320. PubMed ID: 1339110
[TBL] [Abstract][Full Text] [Related]
6. Development of a flow cytometric method to determine DNA ploidy of oesophageal cancer cells obtained by forceps biopsy samples during oesophago-gastro-duodenoscopy.
Rickes S; Hauptmann S; Flath B; Abbenseth R; Zwiebel FM; Possinger K
Onkologie; 2003 Feb; 26(1):32-7. PubMed ID: 12624515
[TBL] [Abstract][Full Text] [Related]
7. Flow-cytometric determination of intracellular pH, esterase activity and cell volume in human leukemic cell lines following in vitro incubation with cytostatic drugs.
Neubauer A; Valet G; Huhn D
Anal Cell Pathol; 1989 Dec; 2(1):49-58. PubMed ID: 2486910
[TBL] [Abstract][Full Text] [Related]
8. Non-small-cell lung carcinoma: tumor characterization on the basis of flow cytometrically determined cellular heterogeneity.
Teodori L; Tirindelli-Danesi D; Mauro F; De Vita R; Uccelli R; Botti C; Modini C; Nervi C; Stipa S
Cytometry; 1983 Sep; 4(2):174-83. PubMed ID: 6313307
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric parameters of neutrophil function as early indicators of sepsis- or trauma-related pulmonary or cardiovascular organ failure.
Rothe G; Kellermann W; Valet G
J Lab Clin Med; 1990 Jan; 115(1):52-61. PubMed ID: 2105366
[TBL] [Abstract][Full Text] [Related]
10. DNA in situ sensitivity to denaturation: a new parameter for flow cytometry of normal human colonic epithelium and colon carcinoma.
Kunicka JE; Darzynkiewicz Z; Melamed MR
Cancer Res; 1987 Aug; 47(15):3942-7. PubMed ID: 3607742
[TBL] [Abstract][Full Text] [Related]
11. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
12. The importance of heterogeneity and of multiple site sampling in the prospective determination of deoxyribonucleic acid flow cytometry.
Stipa S; Danesi DT; Modini C; Cicconetti F; Mauro F; Schillaci A; Mecozzi A; Nicolanti V; Stipa F; Mancini M
Surg Gynecol Obstet; 1993 May; 176(5):427-34. PubMed ID: 8386859
[TBL] [Abstract][Full Text] [Related]
13. [Flow cytometric DNA measurements of thyroid carcinomas].
Tsuchiya A; Sekikawa K; Kimijima I; Suzuki S; Nihei M; Rokkaku Y; Abe R
Gan No Rinsho; 1989 Jul; 35(8):886-90. PubMed ID: 2746864
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric DNA analysis of normal and cancerous human endometrium and cytological-histopathological correlations.
Lindahl B; Alm P; Killander D; Långström E; Tropé C
Anticancer Res; 1987; 7(4B):781-9. PubMed ID: 3674763
[TBL] [Abstract][Full Text] [Related]
15. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
Hass HG; Schmidt A; Nehls O; Kaiser S
Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
[TBL] [Abstract][Full Text] [Related]
16. [Characteristics and problems of flow cytometric nuclear DNA content analysis in lung cancer using bronchoscopically-obtained specimens].
Ariyoshi I
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Sep; 30(9):1704-10. PubMed ID: 1333022
[TBL] [Abstract][Full Text] [Related]
17. [Detection of intratumoral DNA heterogeneity in primary lung cancer using a multiple sampling method].
Mizobuchi K; Fujita Y; Hashikura H; Arimoto T; Nakagaki Y; Goto T; Fujii T; Iwasaki Y; Nakamura T; Nakagawa M
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Oct; 32(10):963-9. PubMed ID: 7844914
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometry as a tool for the prognostic assessment of patients with lung and ovarian carcinomas.
Volm M; Drings P; Kleine W; Mattern J
Strahlenther Onkol; 1987 Dec; 163(12):791-4. PubMed ID: 2827331
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the malignancy of breast carcinoma using flow cytometry].
Ueki H; Abe R; Kimura M; Kasai M
Gan No Rinsho; 1985 Jul; 31(8):929-32. PubMed ID: 2993696
[TBL] [Abstract][Full Text] [Related]
20. Nuclear DNA measurements in squamous cell carcinoma of the lung: a guide for prognostic evaluation.
Blöndal T; Bengtsson A
Anticancer Res; 1981; 1(2):79-86. PubMed ID: 7051956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
